Julie Parmentier

Identification and Characterization of MEDI4736, an Antagonistic Anti–PD-L1 Monoclonal Antibody

Ross Stewart, Michelle Morrow, Scott A. Hammond et al. · Cancer Immunology Research · 2015 · 398 citations

Immunology, Immunoediting, Immunologic Mechanism +20

In vitro and in vivo characterization of the JAK1 selectivity of upadacitinib (ABT-494)

Julie Parmentier, J W Voss, Candace Graff et al. · BMC Rheumatology · 2018 · 352 citations · Full text

Effects of the JAK2 Inhibitor, AZ960, on Pim/BAD/BCL-xL Survival Signaling in the Human JAK2 V617F Cell Line SET-2

Joseph M. Gozgit, Geraldine Bebernitz, Pankaj Patil et al. · Journal of Biological Chemistry · 2008 · 101 citations · Full text

Phenotypic screening reveals TNFR2 as a promising target for cancer immunotherapy

Geoffrey S. Williams, Bina Mistry, Sandrine Guillard et al. · Oncotarget · 2016 · 54 citations · Full text

Synergistic induction of apoptosis by combination of BTK and dual mTORC1/2 inhibitors in diffuse large B cell lymphoma

Scott A. Ezell, Michele Mayo, Teeru Bihani et al. · Oncotarget · 2014 · 53 citations · Full text

Dual Mtorc1/2 Inhibitors, Immunology, Pathology +21